Please Wait a Moment
X

Articles

08Sep

Dr. Marion Lanteri Joins Creative Testing Solutions as Scientific Affairs VP

08 Sep, 2022 | Return|

TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solutions’ vice president of scientific affairs. CTS is a leading research partner, tracking infectious disease markers in the national blood supply, among many other significant projects. As the largest nonprofit blood and plasma laboratory organization in the world, CTS exists to ensure the safety of blood and plasma-derived products for life-saving transfusion and therapeutic use.

Lanteri will lead all CTS’s scientific activities, clinical trials, research, data collection, analysis, and publication in this first-ever dedicated role for CTS.

“Blood transfusions and blood derivatives are integral to patient’s healthcare. Blood screening plays a critical role in blood safety, of which blood donor research is a key component of this process,” says Lanteri. “I am honored to continue to serve as a leader in this important endeavor, something I’ve strived to do over my nearly 20-year career.”

Lanteri’s experience includes 12 years with Vitalant Research Institute in San Francisco. She began there as a post-doctoral student researching immunology and specializing in West Nile, dengue, and Zika virus research and in pathogen inactivation. She has and continues to serve as an assistant adjunct professor at the University of California San Francisco Department of Laboratory Medicine.

Lanteri holds a doctorate in molecular biology and virology, specifically studying HIV at the University of Nice Sophia-Antipolis in France. She is a member of the American Society for Virology, the Association for the Advancement of Blood and Biotherapies, and the International Society of Blood Transfusion. Lanteri has authored or co-authored over 60 peer-reviewed publications.

About Creative Testing Solutions

Creative Testing Solutions provides high-volume donor testing for over 22 million blood and plasma donations annually and tests samples of each unit for all of the viral marker and screening tests required by the Food and Drug Administration. CTS is the world's largest nonprofit blood and plasma donor testing laboratory organization, partnering with over 100 healthcare entities. Our more than 1,000 team members reside remotely or in eight testing labs in Austin, Texas; Phoenix, Arizona; Dallas, Texas; Tampa, Florida; Charlotte, Memphis, Tennessee; North Carolina; St. Louis, Missouri; and San Marcos, Texas. CTS is a 501(c)(3) organization governed by a board of 11 directors.

 

 

 

 

Related

New Online Learning Center with New Content

The new online Learning Center with new content can still be found under the “Training” folder on ...

Read More >

FDA Guidance ZIKV Testing Strategy Webinar

On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...

Read More >

Reminder- Check flights and cargo hours for the Memorial Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

CTS to Implement Donor HLA testing on the Stratec Gemini Instrument

On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...

Read More >

COVID-19 Antibody Testing Frequently Asked Questions

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

Read More >

Renewed NYSDOH licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >